# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-066731
Filing Date
2025-07-09
Accepted
2025-07-09 16:50:36
Documents
21
Period of Report
2025-08-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | tm2520034-2_def14a.htm iXBRL | DEF 14A | 666935
6 | GRAPHIC | bc_paidvsnetloss-bw.jpg | GRAPHIC | 42163
7 | GRAPHIC | bc_paidvstsr-bw.jpg | GRAPHIC | 43223
8 | GRAPHIC | lg_therivabiologics-bwlr.jpg | GRAPHIC | 15069
9 | GRAPHIC | px_25therivaannual1-bw.jpg | GRAPHIC | 306270
10 | GRAPHIC | px_25therivaannual2-bw.jpg | GRAPHIC | 205437
| Complete submission text file | 0001104659-25-066731.txt |  | 2983188

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | tovx-20241231.xsd | EX-101.SCH | 9826
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | tovx-20241231_def.xml | EX-101.DEF | 2630
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tovx-20241231_lab.xml | EX-101.LAB | 35737
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tovx-20241231_pre.xml | EX-101.PRE | 1781
23 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2520034-2_def14a_htm.xml | XML | 195376

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12584 | Film No.: 251114076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)